RIGI and nasopharyngeal carcinoma: To investigate the relationship between RIG‐I and paclitaxel resistance in NPC cells, we established paclitaxel‐resistant NPC cells that overexpress RIG‐I (CNE1‐T and CNE2‐T) (Figure S2A,B).